The Evolving Role of Sites in Decentralized Clinical Trials
Join ERT at Future Trials Conference: Decentralized, Direct-to-Patient & Virtual Clinical Trials on June 22nd, 2021 at 2:30 pm ET for an insightful presentation by Elisa Cascade, EVP, eCOA at ERT, on The Evolving Role of Sites in Decentralized Clinical Trials.
This presentation will discuss how as decentralized clinical trials continue to grow, the role of sites is changing. Sites must be able to understand what solutions and support they will need to ensure their decentralized trials are a success.
- The vital and changing role of sites in hybrid and decentralized clinical trials
- Areas for site readiness in study delivery
- Need for industry collaboration in supporting site readiness
As Executive Vice President and Product Line Executive for eCOA at ERT, Elisa is responsible for business/market planning, advancing the Product portfolio, and maintaining business relationships in the eCOA space. She has over 25 years of experience in strategy consulting, clinical research, market research, brand strategy, salesforce deployment, health economics, and pricing. Prior to joining ERT, Elisa was a Chief Product Officer at IQVIA Technologies, where she was responsible for the development and maintenance of site-facing technology and served as the Lead for the industry collaborations: the Investigator Databank and TransCelerate Investigator Registry.